stent

Multislice computed tomography for bioresorbable scaffolds: the end of invasive diagnostic studies?

Original title:&nbsp;Multislice Computed Tomography Angiography for Non-invasive Assessment of the 18-Months Performance of a Novel Radiolucent Bioresorbable Vascular Scaffolding Device (ABSORB Trial).&nbsp;Reference:&nbsp;Koen Nieman et al. J Am Coll Cardiol, article in press. Metal stents revolutionized coronary angioplasty procedures; however, they are permanent prosthetic devices that make re intervention difficult and prolongue thrombosis risk. This problem<a href="https://solaci.org/en/2013/08/14/multislice-computed-tomography-for-bioresorbable-scaffolds-the-end-of-invasive-diagnostic-studies/" title="Read more" >...</a>

Carotid angioplasty prior to central venous catheter. The best option to solve combined problems.

Original title:&nbsp;A Direct Comparison of Early and Late Outcomes with Three Approaches to Carotid Revascularization and Open Heart Surgery.&nbsp;Reference:&nbsp;Mehdi H. Shishehbor et al. J Am Coll Cardiol, article in press. &nbsp; The prevalence of severe carotid stenosis (&gt; 80%) in patients planning to have a Central Venous Catheter (CVC) is estimated at between 6 and<a href="https://solaci.org/en/2013/08/08/carotid-angioplasty-prior-to-central-venous-catheter-the-best-option-to-solve-combined-problems/" title="Read more" >...</a>

Riociguat, a new drug for pulmonary arterial hypertension

T&iacute;tulo original:&nbsp;Riociguat for the Treatment of Pulmonary Arterial Hypertension.&nbsp;Referencia:&nbsp;Hossein-Ardeschir Ghofrani et al. N Engl J Med 2013;369:330-40. &nbsp; Many drugs have been tested for pulmonary arterial hypertension (PAH) including PDE5 inhibitors, prostanoids and endothelin receptor antagonists, however there are still missed targets in the treatment of this disease. Riociguat is a drug belonging to a<a href="https://solaci.org/en/2013/07/31/riociguat-a-new-drug-for-pulmonary-arterial-hypertension/" title="Read more" >...</a>

The Importance of TIMI 3 flow in primary angioplasty

Original title:&nbsp;Predicitors of suboptimal TIMI flow alter primary angioplasty for acute myocardial infarction: results from the HORIZON-AMI trial.&nbsp;Reference:&nbsp;Adriano Caixeta et al. &nbsp;Eurointervention 2013;9:220-227 Primary angioplasty showed greater efficacy than thrombolytics but one out of every four patients cannot achieve TIMI 3 flow. The Horizons-AMI trial randomized 3,602 patients to receive bivalirudin or heparin plus inhibitors<a href="https://solaci.org/en/2013/07/05/the-importance-of-timi-3-flow-in-primary-angioplasty/" title="Read more" >...</a>

DES versus Bare in primary angioplasty at five years. Initial advantage is reducing

Original: title&nbsp;Long-Term Outcome After Drug-Eluting VersusBare-Metal Stent Implantation in Patients WithST-Segment Elevation Myocardial Infarction. 5 Years Follow-Up From the Randomized DEDICATION (Drug Elution and DistalProtection in Acute Myocardial Infarction) Trial.&nbsp;Reference:&nbsp;Lene Holmvang et al. J Am CollCardiolIntv 2013, article in press. &nbsp; Primary angioplasty reduced mortality and reinfarction compared with thrombolytics in patients experiencing an ST<a href="https://solaci.org/en/2013/07/05/des-versus-bare-in-primary-angioplasty-at-five-years-initial-advantage-is-reducing/" title="Read more" >...</a>

Asymptomatic carotid injury, a disease not so silent

Original title:&nbsp;Association of the Recovery of Objective Abnormal CerebralPerfusion with Neurocognitive Improvement after CarotidRevascularization.&nbsp;Reference:&nbsp;Ching-Chang Huanget al. J Am CollCardiol 2013. Article in press. Cognitive impairment was observed in patients with severe asymptomatic carotid injury but a possible explanation for this is hyper-perfusion. Intuitively restored flow may improve neurocognitive capacity but so far studies have been<a href="https://solaci.org/en/2013/07/04/asymptomatic-carotid-injury-a-disease-not-so-silent/" title="Read more" >...</a>

Result of bifurcated devices to protect the internal iliac in aorto-iliac aneurysms

Original title:&nbsp;Endovascular Treatment of Aorto-iliac Aneurysms: Four-year Results of Iliac Branch Endograft.&nbsp;Reference:&nbsp;G. Pratesi et al. Eur J Vasc Endovasc Surg. 2013 Jun;45(6):607-9. Iliac bifurcated devices have proven to be effective in treating common iliac aneurysms but the findings are based on small series, generally from a sole center experience. This multicenter registry included 85 patients<a href="https://solaci.org/en/2013/06/30/result-of-bifurcated-devices-to-protect-the-internal-iliac-in-aorto-iliac-aneurysms/" title="Read more" >...</a>

Endovascular or surgical popliteal aneurysms exclusion &#8211; both with good results but for different patients.

Original title:&nbsp;A Multicentric Experience with Open Surgical Repair and Endovascular Exclusion of Popliteal Artery Aneurysms.&nbsp;Reference:&nbsp;R. Pulli et al. European Journal of Vascular and Endovascular Surgery, Volume 45, Issue 4, Pages 357-363. &nbsp; Complications of a popliteal aneurysm may cause rupture, distal embolization or thrombosis with a risk of any of them affecting the lower limb.<a href="https://solaci.org/en/2013/06/26/endovascular-or-surgical-popliteal-aneurysms-exclusion-both-with-good-results-but-for-different-patients/" title="Read more" >...</a>

Angioplasty to common femoral artery begins to emerge as an alternative to surgery

Original title:&nbsp;Acute and Medium-Term Outcomes of Endovascular Therapy of Obstructive Disease of Diverse Etiology of the Common Femoral Artery.&nbsp;Reference:&nbsp;Philip B. Dattilo et al. Catheterization and Cardiovascular Interventions 81:1013&ndash;1022 (2013). Surgical endarterectomy is established as the gold standard for treating injuries to common femoral artery since angioplasty presents some difficulties due to the risk of compromising<a href="https://solaci.org/en/2013/06/19/angioplasty-to-common-femoral-artery-begins-to-emerge-as-an-alternative-to-surgery/" title="Read more" >...</a>

Double DES in bifurcations, double thrombosis risk

Original title:&nbsp;Late Thrombosis After Double Versus Single Drug-Eluting Stent in the Treatment of Coronary Bifurcations A Meta-analysis of Randomized and Observational Studies.&nbsp;Reference:&nbsp;Marco Zimarino et al. J Am Coll Cardiol Intv 2013. Article in press. In the era of drug-eluting stents, (DES), several randomized and observational studies have been conducted trying to find the best strategy<a href="https://solaci.org/en/2013/06/14/double-des-in-bifurcations-double-thrombosis-risk/" title="Read more" >...</a>

Top